Washington, D.C.–Pharmaceutical company Actelion Pharmaceuticals US, Incorporated, based in South San Francisco, has agreed to pay $360 million to resolve claims that it illegally used a foundation as a conduit to pay the copays of thousands of Medicare patients taking Actelion’s pulmonary arterial hypertension drugs, in violation of the False Claims Act, the Justice Department […]